ARROWSTREET CAPITAL, LIMITED PARTNERSHIP – Abbott Laboratories Transaction History
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP portfolio value:
$641.16M
portfolio value
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP quarter portfolio value change:
-10.94%
quarter
Abbott Laboratories 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +14.11% | 819.48K shares | 10.24M | $96.76 | 6.62M |
| Q2 2022 | share | Increase | +17.91% | 881.86K shares | 47.99M | $108.65 | 5.80M |
| Q1 2022 | share | Increase | +83.11% | 2.23M shares | 204.37M | $118.36 | 4.92M |
| Q4 2021 | share | Increase | +45.46% | 840.64K shares | 160.11M | $141 | 2.68M |
| Q3 2021 | share | Increase | +56.08% | 664.35K shares | 81.08M | $117.68 | 1.84M |
| Q2 2021 | share | Increase | +1759.81% | 1.12M shares | 129.70M | $115.05 | 1.18M |
| Q1 2021 | share | Decrease | -49.40% | -62.2K shares | -6.15M | $118.49 | 63.7K |
| Q4 2020 | share | Increase | +1014.16% | 114.6K shares | 12.55M | $107.81 | 125.9K |
| Q3 2020 | share | Decrease | -88.36% | -85.79K shares | -7.64M | $106.81 | 11.3K |
| Q2 2020 | share | Decrease | -69.13% | -217.40K shares | -15.93M | $89.39 | 97.09K |
| Q1 2020 | share | Increase | 0.00% | 314.5K shares | 24.81M | $76.84 | 314.5K |
| Q3 2018 | share | Decrease | -100.00% | -8.8K shares | -537K | $69.69 | 0 |
| Q2 2018 | share | Decrease | -81.55% | -38.9K shares | -2.32M | $57.68 | 8.8K |
| Q1 2018 | share | Increase | +77.99% | 20.9K shares | 1.32M | $56.4 | 47.7K |
| Q4 2017 | share | Increase | 0.00% | 26.8K shares | 1.52M | $53.46 | 26.8K |